International Journal of Cardiology

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

Radiofrequency catheter ablation of incessant atrial tachycardia in pregnant women with minimal radiation exposure: Lessons from two case studies Pil-Sung.

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Non-valvular Atrial Fibrillation.

Volume 70, Issue 1, Pages (July 2017)

Volume 30, Issue 1, Pages (February 2014)

Volume 29, Issue 3, Pages (June 2013)

Volume 28, Issue 6, Pages (December 2012)

Frontiers of anticoagulation therapy for atrial fibrillation

Refractory variant angina with a seasonal trend treated with sarpogrelate hydrochloride Fumio Liu, MD, Hiroshi Wada, MD, Kenichi Sakakura, MD, Taishi.

Volume 42, Issue 3, Pages (March 2005)

Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

Prestroke Glycemic Control Is Associated With the Functional Outcome in Acute Ischemic Stroke by Masahiro Kamouchi, Takayuki Matsuki, Jun Hata, Takahiro.

Peak C-Reactive Protein Level Predicts Long-Term Outcomes in Type B Acute Aortic Dissection by Kenichi Sakakura, Norifumi Kubo, Junya Ako, Hiroshi Wada,

Patients with epilepsy are at an increased risk of subsequent stroke: A population-based cohort study Chen-Shu Chang, Chun-Hui Liao, Che-Chen Lin, Hsien-Yuan.

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal Gregory.

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis Sarah A. Anderson, John.

Epicardial and endocardial electrophysiological guided thoracoscopic surgery for atrial fibrillation: A multidisciplinary approach of atrial fibrillation.

Valvular heart disease in pregnancy: A review

Comparison of chronic type A aortic dissection with acute type A dissection of short-term and long-term survival rate Qinghua Yuan, Hui Yu, Ujit Karmacharya,

Clinicopathological features of long-term survivors for advanced biliary tract cancer and impact of the number of lymph nodes involved Shogo Kobayashi,

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

International Journal of Cardiology

Journal of Indian College of Cardiology

Volume 42, Issue 3, Pages (March 2005)

Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator? Maura Ravera, Elisabetta.

Impact of non-cardiovascular disease comorbidity on cardiovascular disease symptom severity: A population-based study C.A. Rushton, U.T. Kadam International.

Development of a risk of stroke score in the Lebanese population

Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without.

Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trial Marie-Claude Morice, Suneel Talwar, Oliver.

Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population Paul D. Ziegler, John D. Rogers,

History of Thyroid Disorders in Relation to Clinical Outcomes in Atrial Fibrillation Helene Bruere, MD, Laurent Fauchier, MD, PhD, Anne Bernard Brunet,

International Journal of Cardiology

Tetsuro Tsujimoto, Hiroshi Kajio International Journal of Cardiology

One-year clinical outcomes in older patients with non-ST elevation acute coronary syndrome undergoing coronary angiography: An analysis of the ICON1 study

Improving Outcomes in AF: Do the NOACs Hold Their Promise In The Real World?

Changing axis deviation, paroxysmal atrial fibrillation and elevation of prostate-specific antigen during acute myocardial infarction Salvatore Patanè,

CHA2DS2-VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban W. Frank Peacock, MD, CAPT Sally.

Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review B.A. de Waal, M.P. Buise, A.A.J. van.

International Journal of Cardiology

Epicardial and endocardial electrophysiological guided thoracoscopic surgery for atrial fibrillation: A multidisciplinary approach of atrial fibrillation.

Very long-term clinical outcomes after radiofrequency catheter ablation for atrial fibrillation: A large single-center experience Tetsuma Kawaji, Satoshi.

Clinical importance of short–long–short sequences: Analysing the mode of onset of ventricular tachycardias and atrial fibrillation Bulent Gorenek International.

International Journal of Cardiology

International Journal of Cardiology

Atrial fibrillation: Improvement in identification and stroke preventive therapy —Data from the UK Clinical Practice Research Datalink, 2000–2012 A.C.E.

5 Good Minutes on Atrial Fibrillation-related Stroke

International Journal of Cardiology

Screening for atrial fibrillation in general practice: A national, cross-sectional study of an innovative technology Gerard Bury, Davina Swan, Walter.

Screening for atrial fibrillation with automated blood pressure measurement: Research evidence and practice recommendations Willem J. Verberk, Stefano.

International Journal of Cardiology

Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease Tetsuro Tsujimoto, Hiroshi Kajio

Comparison of the GRACE, HEART and TIMI score to predict major adverse cardiac events in chest pain patients at the emergency department J.M. Poldervaart,

Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study Walid Saliba, MD, MPH, Naomi.

Erratum to “Tako-tsubo cardiomyopathy may be associated with cardiac geometric features as observed in hypertensive heart disease” [Int. J. Cardiol. 135.

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE.

Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study Hiroshi.

Comparison of Graft-Versus-Host Disease-Free, Relapse-Free Survival (GRFS) of Patients with Hematological Malignancy According to Donor Type: JSHCT Working.

International Journal of Cardiology

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Maxim Grymonprez, Vincent Vakaet, Maryam Kavousi, Bruno H. Stricker, M

Table of contents The Journal for Nurse Practitioners

Right bundle branch block with revelation of changing axis deviation at the end of atrial fibrillation Salvatore Patanè, Filippo Marte, Mauro Sturiale

Erratum Canadian Journal of Cardiology

SAFETY AND EFFICACY OF DABIGATRAN COMPARED TO BRIDGED WARFARIN FOR PERIPROCEDURAL ANTICOAGULATION IN PATIENTS UNDERGOING RADIOFREQUENCY ABLATION FOR.

Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation Finlay A. McAlister,

International Journal of Cardiology

Wee L. , Barron J. , Toye R. British Journal of Anaesthesia

Presentation transcript:

International Journal of Cardiology The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with nonvalvular atrial fibrillation Hiroaki Shimokawa, Takeshi Yamashita, Shinichiro Uchiyama, Takanari Kitazono, Wataru Shimizu, Takanori Ikeda, Masahiro Kamouchi, Koichi Kaikita, Koji Fukuda, Hideki Origasa, Ichiro Sakuma, Keijiro Saku, Yasuo Okumura, Yuichiro Nakamura, Hideo Morimoto, Naoki Matsumoto, Akihito Tsuchida, Junya Ako, Nobuyoshi Sugishita, Shogo Shimizu, Hirotsugu Atarashi, Hiroshi Inoue International Journal of Cardiology Volume 258, Pages 126-132 (May 2018) DOI: 10.1016/j.ijcard.2018.01.141 Copyright © 2018 The Authors Terms and Conditions

Fig. 1 Kaplan–Meier analysis for primary endpoints and all-cause deaths (efficacy and safety populations). International Journal of Cardiology 2018 258, 126-132DOI: (10.1016/j.ijcard.2018.01.141) Copyright © 2018 The Authors Terms and Conditions

Fig. 2 The primary efficacy endpoint (A) (stroke or systemic embolism) and primary safety endpoint (B) (major bleeding) according to CHADS2 and CHA2DS2-VASc scores. International Journal of Cardiology 2018 258, 126-132DOI: (10.1016/j.ijcard.2018.01.141) Copyright © 2018 The Authors Terms and Conditions